Activation of diverse eicosanoid pathways in osteoarthritic cartilage: A lipidomic and genomic analysis

Bulletin of the NYU Hospital for Joint Diseases

Volumn 70, Issue 2, 2012, Pages 99-108

  Attur, Mukundan ^a   Dave, Mandar ^a   Abramson, Steven B ^a,b   Amin, Ashok ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GROWTH FACTOR; ICOSANOID; INDOMETACIN; INTERLEUKIN 1; LIPOXYGENASE; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE;

ARTICLE; CARTILAGE; CARTILAGE CELL; DRUG EFFECT; ENZYME INHIBITION; FOLLOW UP; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIPIDOMICS; OSTEOARTHRITIS; PHARMACOGENOMICS;

CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; CYCLOOXYGENASE 2 INHIBITORS; EICOSANOIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; IMMUNOASSAY; INTERLEUKIN-1; LIPOXYGENASE; METABOLOMICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS, KNEE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION, GENETIC;

EID: 84865023502     PISSN: 19369719     EISSN: 19369727     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Attur MG, Dave NM, Akamatsu M, et al. Osteoarthritis or Osteoarthrosis: The definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage. 2002;10(1):1-4.
2. Amin AR, Attur M, Patel RN, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest. 1997 Mar 15;99(6):1231-7.
3. Amin AR, Di Cesare PE, Vyas P, et al. The expression and regulation of nitric oxide synthase in human osteoarthritisaffected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med. 1995 Dec 1;182(6):2097-102.
4. Amin AR, Attur M, Vyas P, et al. A novel mechanism of action of tetracycline: effects on nitric oxide synthase. Proc Natl Acad Sci USA. 1996 Nov 26;93(24):14014-9.
5. Attur MG, Dave NM, Amin AR. Functional genomic approaches in arthritis. American J Pharmacogenomics. 2004; 4(1):29-43.
6. Crofford LJ, Lipsky PE, Brooks P, et al. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum. 2000 Jan;43(1):4-13.
7. Tanioka T, Nakatani Y, Semmyo N, et al. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem. 2000 Oct 20;275(42):32775-82.
8. Murakami M, Naraba H, Tanioka T, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem. 2000 Oct 20;275(42):32783-92.
9. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999 Oct;79(4):1193-226.
10. Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum. 2003 Dec;33(3):155-67.
11. Dingle JT. Prostaglandins in human cartilage metabolism. J Lipid Mediat. 1993 Mar-Apr;6(1-3):303-12.
12. Raisz LG, Fall PM, Gabbitas BY, et al. Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: role of insulin-like growth factor-I. Endocrinology. 1993 Oct;133(4):1504-10.
13. O'Keefe RJ, Crabb ID, Puzas JE, Rosier RN. Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes. J Bone Miner Res. 1992 Apr;7(4):397-404.
14. Di Battista JA, Doré S, Martel-Pelletier J, Pelletier JP. Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I. Mol Cell Endocrinol. 1996 Oct 14;123(1):27-35.
15. Goldring MB, Berenbaum F. Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression. Osteoarthritis Cartilage. 1999 Jul;7(4):386-8.
16. Mehindate K, al-Daccak R, Dayer JM, et al. Superantigeninduced collagenase gene expression in human IFN-gammatreated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2. J Immunol. 1995 Oct 1;155(7):3570-7.
17. Hardy MM, Seibert K, Manning PT, et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum. 2002 Jul;46(7):1789-803.
18. Kojima F, Naraba H, Miyamoto S, et al. Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res Ther. 2004;6(4):R355-65.
19. Attur MG, Dave MN, Tsunoyama K, et al. "A system biology" approach to bioinformatics and functional genomics in complex human diseases: arthritis. Curr Issues Mol Biol. 2002;4(4):129-46.
20. Attur MG, Dave M, Amin AR. Functional genomics approaches in arthritis. Am J Pharmacogenomics. 2004;4(1):29-43.
21. Attur MG, Dave M, Cipolletta C, et al. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J Biol Chem. 2000 Dec 22;275(51):40307-15.
22. Patel R, Attur MG, Dave M, et al. Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. J Immunol. 1999 Apr 1;162(7):4191-7.
23. Attur MG, Patel I, Patel RN, et al. Autocrine production of IL-1 by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, Prostaglandin E2 and IL-8. Proc of the Assoc of Am Physicians. 1998 Jan-Feb;110(1):65-72.
24. Towle, CA, Hung HH, Bonassar LJ, et al. Detection of interleukin-I in the cartilage of the patients of osteoarthritis; a possible autocrine /paracrine role in pathogenesis. Osteoarthritis Cartilage. 1997 Sep; 5(5):293-300.
25. Poligone B, Baldwin AS. Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. J Biol Chem. 2001 Oct 19;276(42):38658-64.
26. Stichtenoth DO, Thoren S, Bian H, et al. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J Immunol. 2001 Jul 1;167(1):469-74.
27. Masuko-Hongo K, Berenbaum F, Humbert L, et al. Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum. 2004 Sep;50(9):2829-38.
28. Trebino CE, Stock JL, Gibbons CP, et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA. 2003 Jul 22;100(15):9044-9.
29. Gosset M, Pigenet A, Salvat C, et al. Inhibition of matrix metalloproteinase-3 and-13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1. J Immunol. 2010 Nov 15;185(10):6244-52.
30. Attur M, Al-Mussawir HE, Patel J, et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol. 2008 Oct 1;181(7):5082-8.
31. Sato T, Konomi K, Fujii R, et al. Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes. Ann Rheum Dis. 2011 Jan;70(1):221-6.
32. Dave M, Attur M, Palmer G, et al. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum. 2008 Sep; 58(9):2786-97.
33. Curtis CL, Rees SG, Little CB, et al. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum. 2002 Jun;46(6):1544-53.
34. Fermor B, Haribabu B, Weinberg JB, et al. Mechanical stress and nitric oxide influence leukotriene production in cartilage. Biochem Biophys Res Commun. 2001 Jul 20;285(3):806-10.
35. Luo M, Jones SM, Phare SM, et al. Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. J Biol Chem. 2004 Oct 1;279(40):41512-20.
36. Chen SH, Fahmi H, Shi Q, Benderdour M. Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenaseactivating protein/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes. Arthritis Res Ther. 2010;12(1):R21.
37. Cernanec J, Guilak F, Weinberg JB, et al. Influence of hypoxia and reoxygenation on cytokine-induced production of proinflammatory mediators in articular cartilage. Arthritis Rheum. 2002 Apr;46(4):968-75.
38. Zhang Y, McCluskey K, Fujii K, Wahl LM. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and-independent mechanisms. J Immunol. 1998 Sep 15;161(6):3071-6.
39. Salvatori R, Guidon PT Jr., Rapuano BE, Bockman RS. Prostaglandin E1 inhibits collagenase gene expression in rabbit synoviocytes and human fibroblasts. Endocrinology. 1992 Jul;131(1):21-8.
40. DiBattista JA, Martel-Pelletier J, Fujimoto N, et al. Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway. Lab Invest. 1994 Aug;71(2):270-8.
41. Wise H. Multiple signalling options for prostacyclin. Acta Pharmacol Sin. 2003 Jul;24(7):625-30.
42. Murata T, Ushikubi F, Matsuoka T, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 1997 Aug 14;388(6643):678-82.
43. Urade Y, Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm. 2000;58:89-120.
44. Zayed N, Afif H, Chabane N, et al. Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. Arthritis Rheum. 2008 Nov; 58(11):3530-40.
45. Fahmi H, Pelletier JP, Di Battista JA, et al. Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1. Osteoarthritis Cartilage. 2002 Feb;10(2):100-8.
46. Boyault S, Simonin MA, Bianchi A, et al. 15-Deoxydelta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. FEBS Lett. 2001 Jul 13;501(1):24-30.
47. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994 Aug 12; 265(5174):956-9.